Company intelligence / Profile preview

Syntopa

Alameda, California, United Stateslinkedin.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

Syntopa is developing microbial products that accelerate enhanced rock weathering for carbon removal. They have built a collection of over 1,200 rock-weathering soil microbes and are preparing for field trials in 2025, with plans to bring first products to market by 2027[2][3].

Therapeutic areas: Other
Modalities: Microbial productsbiologics
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Syntopa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Syntopa.

Explore the full profile